Pharmacokinetic and pharmacodynamic basis for peptide drug delivery system design
- 31 July 1992
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 21 (1-3), 5-10
- https://doi.org/10.1016/0168-3659(92)90003-a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Peptide-blood-brain barrier interactions: kinetics and dynamicsJournal of Controlled Release, 1992
- Melanocortins in peripheral nerve regeneration: Influence of dosage forms and routes of administrationJournal of Controlled Release, 1990
- Peptide transport across the blood-brain barrierJournal of Controlled Release, 1990
- Transport of peptide and protein drugs across biological membranesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Pharmacokinetic and pharmacodynamic aspects of polypeptide deliveryJournal of Controlled Release, 1990
- Intestinal drug absorption enhancement: An overviewPharmacology & Therapeutics, 1989
- Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: An overviewPharmacology & Therapeutics, 1988
- Pulsatile Insulin Delivery is More Efficient Than Continuous Infusion in Modulating Islet Cell Function in Normal Subjects and Patients with Type 1 DiabetesJournal of Clinical Endocrinology & Metabolism, 1988
- Comparison of the Potential for Therapeutic Utilities with Gonadotropin-Releasing Hormone Agonists and AntagonistsEndocrine Reviews, 1986